FABian® - Applications

Isolation of PBMCs and T cells from human whole blood

Using the FABian® platform, IBA Lifesciences has developed a unique approach for preparing Ficoll gradient-equivalent PBMC fractions in an automated and standardized manner. This process delivers PBMCs of highly reproducible quality from healthy as well as patient donors without the need for Ficoll density centrifugation – a major advance in cell selection for clinical and routine testing as well as research applications.
IBA Lifesciences offers FABian®-based automatic cell selection for specialized cell populations incl. T cells and other cell types. We are continuously expanding our cell selection applications as well as providing fully customized services for our customers.

For more information please visit www.fabian-online.com or watch our video.

Please download your application note of interest:

FABian® – Lymphocyte isolation

FABian® – Lymphocyte isolation Supplementary

FABian® vs Density gradient - Workflow

PBMC like specific cell selection by a Fab-based immune affinity chromatography

The first row of the image shows a 0.12 % share of PBMCs (CD81-positive cells) in the whole blood sample before the selection process.
The second row presents the results of  the positive fraction after selection, indicating an excellent purity of 95 % and a high yield of the  PBMCs (targeted CD81 positive cells).